10/23/2025
Over the last few months, President Donald Trump has gone after the price of prescription drugs. He has signed 17 letters to pharmaceutical company CEOs, setting a 30-day deadline for companies to lower the cost of prescription drugs.
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.
Tradeoffs senior producer Leslie Walker spoke with 10 health policy experts — including health economists, drug policy scholars and industry insiders — who helped explain what this flurry of moves might actually mean for the prices that we pay for the medicines we need.
Listen to the latest episode to hear why experts warn we shouldn’t expect most of these moves to deliver substantive savings — at least not yet.
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.